Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

INTRODUCTION: The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, extension study in patients completing 1 of 2 phase 3 randomized, double-blind, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaeth, Michael, Alegre, Cayetano, Perrot, Serge, Wang, Youyu Grace, Guinta, Diane R, Alvarez-Horine, Sarah, Russell, Irwin Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978755/
https://www.ncbi.nlm.nih.gov/pubmed/24286114
http://dx.doi.org/10.1186/ar4375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978755/
https://www.ncbi.nlm.nih.gov/pubmed/24286114
http://dx.doi.org/10.1186/ar4375

Ejemplares similares